UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Enithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

Stacchiotti, S; Miah, AB; Frezza, AM; Messiou, C; Morosi, C; Caraceni, A; Antonescu, CR; ... Gronchi, A; + view all (2021) Enithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO OPEN , 6 (3) , Article 100170. 10.1016/j.esmoop.2021.100170. Green open access

[thumbnail of 1-s2.0-S2059702921001307-main.pdf]
Preview
Text
1-s2.0-S2059702921001307-main.pdf - Published Version

Download (2MB) | Preview

Abstract

Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. No active systemic agents are currently approved specifically for EHE, which is typically refractory to the antitumor drugs used in sarcomas. The degree of uncertainty in selecting the most appropriate therapy for EHE patients and the lack of guidelines on the clinical management of the disease make the adoption of new treatments inconsistent across the world, resulting in suboptimal outcomes for many EHE patients. To address the shortcoming, a global consensus meeting was organized in December 2020 under the umbrella of the European Society for Medical Oncology (ESMO) involving >80 experts from several disciplines from Europe, North America and Asia, together with a patient representative from the EHE Group, a global, disease-specific patient advocacy group, and Sarcoma Patient EuroNet (SPAEN). The meeting was aimed at defining, by consensus, evidence-based best practices for the optimal approach to primary and metastatic EHE. The consensus achieved during that meeting is the subject of the present publication.

Type: Article
Title: Enithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.esmoop.2021.100170
Publisher version: https://doi.org/10.1016/j.esmoop.2021.100170
Language: English
Additional information: © 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: sarcoma, epithelioid hemangioendothelioma, diagnosis, treatment, management, guidelines
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: https://discovery.ucl.ac.uk/id/eprint/10131128
Downloads since deposit
29Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item